LeadIQ logo
Learn more at LeadIQ.com

Insights

Early Detection Breath Diagnostics has a patented exhale testing platform claimed to detect lung cancer with parts-per-billion accuracy, presenting a compelling value proposition for early diagnosis initiatives and payer-supported screening programs.

AI Driven Recent and upcoming development efforts focus on an AI-powered breath analysis platform to identify disease signatures, signaling opportunities to partner on data science validation, clinical trials, and integration with existing diagnostic workflows.

Strategic Growth News of leadership expansion and advanced product development suggests readiness to scale operations, pursue larger clinical collaborations, and commercialize OneBreath in multi-market settings.

Funding & Scale Current revenue range and modest funding indicate potential for channel partnerships, contract research opportunities, and collaboration with biopharma, imaging, and healthcare providers seeking non-invasive screening solutions.

Technology Stack Utilizing cloud, web, and API-enabled tools (AWS, Google Cloud, Mailgun, Webflow) positions the company to integrate with hospital IT systems, data platforms, and telehealth services, enabling scalable deployment and secure data exchange.

Similar companies to Breath Diagnostics, Inc.

Breath Diagnostics, Inc. Tech Stack

Breath Diagnostics, Inc. uses 8 technology products and services including Amazon Web Services, cdnjs, Google Workspace, and more. Explore Breath Diagnostics, Inc.'s tech stack below.

Breath Diagnostics, Inc.'s Email Address Formats

Breath Diagnostics, Inc. uses at least 3 email formats:
Breath Diagnostics, Inc. Email FormatsExamplePercentage
First.Last@breathdiagnosticsinc.comJohn.Doe@breathdiagnosticsinc.com
83%
First.MiddleLast@breathdiagnosticsinc.comJohn.MichaelDoe@breathdiagnosticsinc.com
17%
FLast@breathdiagnostics.comJDoe@breathdiagnostics.com
100%

Frequently Asked Questions

What is Breath Diagnostics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconBreath Diagnostics, Inc.'s official website is breathdiagnostics.com and has social profiles on LinkedIn.

How much revenue does Breath Diagnostics, Inc. generate?

Minus sign iconPlus sign icon As of August 2026, Breath Diagnostics, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Breath Diagnostics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign iconBreath Diagnostics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Breath Diagnostics, Inc. have currently?

Minus sign iconPlus sign iconAs of August 2026, Breath Diagnostics, Inc. has approximately 10 employees across 1 continents, including North America. Key team members include Chief Executive Officer: I. L., President: A. R. and Research Associate: R. J. Explore Breath Diagnostics, Inc.'s employee directory with LeadIQ.

What industry does Breath Diagnostics, Inc. belong to?

Minus sign iconPlus sign iconBreath Diagnostics, Inc. operates in the Biotechnology Research industry.

What technology does Breath Diagnostics, Inc. use?

Minus sign iconPlus sign iconBreath Diagnostics, Inc.'s tech stack includes Amazon Web Services, cdnjs, Google Workspace, Mailgun, Google Cloud, MailerLite, Webflow and HTTP/3.

What is Breath Diagnostics, Inc.'s email format?

Minus sign iconPlus sign iconBreath Diagnostics, Inc.'s email format typically follows the pattern of First.Last@breathdiagnosticsinc.com. Find more Breath Diagnostics, Inc. email formats with LeadIQ.

How much funding has Breath Diagnostics, Inc. raised to date?

Minus sign iconPlus sign icon As of August 2026, Breath Diagnostics, Inc. has raised $250K in funding. The last funding round occurred on Mar 11, 2020.
Breath Diagnostics, Inc. logo

Breath Diagnostics, Inc.

Biotechnology ResearchKentucky, United States2-10 Employees

Breath Diagnostics, Inc. operates in the biotechnology research space with a focus on non-invasive lung cancer detection. The company has developed a patented breath-analysis approach that aims to determine whether a patient has lung cancer by analyzing exhaled breath with parts-per-billion accuracy, enabling very early detection. The technology has been studied in more than 800 patients, highlighting its potential to influence diagnostic pathways.

Based in Louisville, Kentucky, the company comprises a small, specialized team within the biotechnology research sector. In late October 2024, Breath Diagnostics announced the appointment of Aaron Roebuck as President. The company appears to target healthcare providers and patients seeking early, non-invasive screening for lung cancer, addressing the need for accurate, minimally invasive diagnostic options.

Section iconCompany Overview

Website
breathdiagnostics.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $250K

    Breath Diagnostics, Inc. has raised a total of $250K of funding over 3 rounds. Their latest funding round was raised on Mar 11, 2020 as a Venture Round.

  • $10M - $25M

    Breath Diagnostics, Inc.'s revenue is estimated to be in the range of $10M - $25M

Company Leadership

  • Chief Executive Officer at Breath Diagnostics, Inc.
    I. L.
    Chief Executive Officer
    Mobile Phone
  • President at Breath Diagnostics, Inc.
    A. R.
    President
    Mobile Phone
  • Research Associate at Breath Diagnostics, Inc.
    R. J.
    Research Associate
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.